Study [references] |
Duration study conducted |
Radiation
techniques |
Mean
Radiation doses |
Sample size
(n) |
Follow up period |
Loco-
regional Control |
Freedom From Distant Metastasis |
Overall survival |
Grade 3 Acute toxicity
incidence |
Grade 3 Late
toxicity |
Schwartz DL [7] |
1996-2005 |
74→3DCRT
57→IMRT |
60Gy/30fr |
131 |
4 years |
79% |
76% |
73% |
NA |
2% |
Rosenbluth BD[8] |
2001-2004 |
IMRT |
63Gy/30fr |
20 |
2 years |
85% |
46% |
60% |
50% |
None |
Urbano TG [9] |
2005-2006 |
IMRT |
58.8Gy/28fr |
13 |
2 years |
90% |
87% |
NA |
8-31% |
NA |
Turaka A [10] |
2001-2008 |
IMRT |
60Gy/30fr |
10 |
2years |
90% |
87% |
80% |
10-30% |
None |
Our study |
2007-2011 |
IMRT |
66Gy/33fr |
18 |
4 years |
88.9% |
83.2% |
89.4% |
5.5% |
None |
3DCRT= Three dimensional conformal Radiation therapy, IMRT= Intensity modulated Radiation Therapy, Gy=Grays, NA= not available |